NEORX CORPORATION, A CORP. OF WA
Patent Owner
Stats
- 0 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 18, 2003 most recent publication
Details
- 0 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,626 Total Citation Count
- Mar 12, 1986 Earliest Filing
- 40 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
- No Technology to Display
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
- No Recent Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
6534037 Non-steroidal compounds for steroid receptors and uses relating theretoExpiredAug 22, 00Mar 18, 03[A61K]
5684137 S.sub.3 N chelating compounds for the radiolabeling of ligands, anti-ligands or other proteinsExpiredFeb 22, 95Nov 04, 97[C07F, C07D, C07K]
5322678 Alteration of pharmacokinetics of proteins by charge modificationExpiredFeb 17, 88Jun 21, 94[A61K]
5217705 Method of diagnosing blood clots using fibrin-binding proteinsExpiredSep 22, 88Jun 08, 93[A61K]
5213787 Radiohalogenated small molecules for protein labelingExpiredDec 12, 90May 25, 93[A61K, C07C]
5175257 Radiolabeled proteins for diagnostic or therapeutic useExpiredJan 14, 91Dec 29, 92[A61K, C07K]
5169933 Covalently-linked complexes and methods for enhanced cytotoxicity and imagingExpiredAug 07, 89Dec 08, 92[A61K, C07K]
5164176 Radionuclide metal chelates for the radiolabeling of proteinsExpiredSep 05, 90Nov 17, 92[A61K]
5116944 Conjugates having improved characteristics for in vivo administrationExpiredDec 29, 89May 26, 92[C07K]
5112953 Radiolabeled proteins for diagnostic or therapeutic useExpiredDec 29, 89May 12, 92[A16K, C07K]
5102651 Process for isolation and radiolabeling of pharmaceuticals with isotopes of astatineExpiredDec 29, 89Apr 07, 92[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.